These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Patterns of cholinesterase-inhibitor use in the nursing home setting: a retrospective analysis. Dybicz SB; Keohane DJ; Erwin WG; McRae T; Shah SN Am J Geriatr Pharmacother; 2006 Jun; 4(2):154-60. PubMed ID: 16860262 [TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis. Tan CC; Yu JT; Wang HF; Tan MS; Meng XF; Wang C; Jiang T; Zhu XC; Tan L J Alzheimers Dis; 2014; 41(2):615-31. PubMed ID: 24662102 [TBL] [Abstract][Full Text] [Related]
32. Cholinesterase inhibitor discontinuation in patients with Alzheimer's disease: a meta-analysis of randomized controlled trials. O'Regan J; Lanctôt KL; Mazereeuw G; Herrmann N J Clin Psychiatry; 2015 Nov; 76(11):e1424-31. PubMed ID: 26646039 [TBL] [Abstract][Full Text] [Related]
33. Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials. Atri A; Frölich L; Ballard C; Tariot PN; Molinuevo JL; Boneva N; Windfeld K; Raket LL; Cummings JL JAMA; 2018 Jan; 319(2):130-142. PubMed ID: 29318278 [TBL] [Abstract][Full Text] [Related]
34. Predictive factors of discontinuation and switch of cholinesterase inhibitors in community-dwelling patients with Alzheimer's disease: a 2-year prospective, multicentre, cohort study. Gardette V; Andrieu S; Lapeyre-Mestre M; Coley N; Cantet C; Ousset PJ; Grand A; Monstastruc JL; Vellas B CNS Drugs; 2010 May; 24(5):431-42. PubMed ID: 20369907 [TBL] [Abstract][Full Text] [Related]
35. Donepezil for dementia due to Alzheimer's disease. Birks J; Harvey RJ Cochrane Database Syst Rev; 2006 Jan; (1):CD001190. PubMed ID: 16437430 [TBL] [Abstract][Full Text] [Related]